Literature DB >> 18710388

Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosis.

AnnaCarin Horne1, Kim Göransdotter Ramme, Eva Rudd, Chengyun Zheng, Yasser Wali, Zakia al-Lamki, Aytemiz Gürgey, Nevin Yalman, Magnus Nordenskjöld, Jan-Inge Henter.   

Abstract

Familial hemophagocytic lymphohistiocytosis (FHL) is a rare autosomal recessive lethal condition characterized by fever, cytopenia, hepatosplenomegaly and hemophagocytosis. The hallmark of FHL is defect apoptosis triggering and lymphocyte cellular cytotoxicity. Thus far three disease-causing genes (PRF1, UNC13D, STX11) have been identified. We performed a genotype-phenotype study in a large, multi-ethnic cohort of 76 FHL patients originating from 65 unrelated families. Biallelic mutations in PRF1, UNC13D and STX11 were demonstrated in 13/74 (18%), 6/61 (10%) and 14/70 (20%) patients, respectively. In 27/60 (45%) patients analyzed for all three genes, no molecular diagnosis was established. STX11 mutations were most common in Turkish families (7/28, 25%), whereas in Middle East families, PRF1 mutations were most frequent (6/13, 46%). No biallelic mutation was identified in most families of Nordic origin (13/14, 93%). Patients carrying PRF1 mutations had higher risk of early onset (age <6 months) compared to patients carrying STX11 mutations [adjusted odds ratio 8.23 (95% confidence interval [CI] = 1.20-56.40), P = 0.032]. Moreover, patients without identified mutations had increased risk of pathological cerebrospinal fluid (CSF) at diagnosis compared to patients with STX11 mutations [adjusted odds ratio 26.37 (CI = 1.90-366.82), P = 0.015]. These results indicate that the disease-causing mutations in FHL have different phenotypes with regard to ethnic origin, age at onset, and pathological CSF at diagnosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18710388     DOI: 10.1111/j.1365-2141.2008.07315.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  26 in total

1.  Structural and functional analysis of perforin mutations in association with clinical data of familial hemophagocytic lymphohistiocytosis type 2 (FHL2) patients.

Authors:  Omer An; Attila Gursoy; Aytemiz Gurgey; Ozlem Keskin
Journal:  Protein Sci       Date:  2013-06       Impact factor: 6.725

Review 2.  Hemophagocytic Syndrome and Critical Illness: New Insights into Diagnosis and Management.

Authors:  Zuzana Tothova; Nancy Berliner
Journal:  J Intensive Care Med       Date:  2014-01-08       Impact factor: 3.510

3.  Exome sequencing for simultaneous mutation screening in children with hemophagocytic lymphohistiocytosis.

Authors:  Ekchol Mukda; Objoon Trachoo; Ekawat Pasomsub; Rawiphorn Tiyasirichokchai; Nareenart Iemwimangsa; Darintr Sosothikul; Wasun Chantratita; Samart Pakakasama
Journal:  Int J Hematol       Date:  2017-03-28       Impact factor: 2.490

Review 4.  Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management.

Authors:  C Gholam; S Grigoriadou; K C Gilmour; H B Gaspar
Journal:  Clin Exp Immunol       Date:  2011-03       Impact factor: 4.330

5.  Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases.

Authors:  Jan Rohr; Karin Beutel; Andrea Maul-Pavicic; Thomas Vraetz; Jens Thiel; Klaus Warnatz; Ilka Bondzio; Ute Gross-Wieltsch; Michael Schündeln; Barbara Schütz; Wilhelm Woessmann; Andreas H Groll; Brigitte Strahm; Julia Pagel; Carsten Speckmann; Gritta Janka; Gillian Griffiths; Klaus Schwarz; Udo zur Stadt; Stephan Ehl
Journal:  Haematologica       Date:  2010-09-07       Impact factor: 9.941

6.  UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis.

Authors:  Hoi Soo Yoon; Hee-Jin Kim; Keon-Hee Yoo; Ki-Woong Sung; Hong-Hoe Koo; Hyoung Jin Kang; Hee Young Shin; Hyo Seop Ahn; Ji-Yoon Kim; Young-Tak Lim; Keun-Wook Bae; Ki-O Lee; Ji-Sook Shin; Seung-Tae Lee; Hae-Sun Chung; Sun-Hee Kim; Chan-Jeoung Park; Hyun-Sook Chi; Ho-Joon Im; Jong Jin Seo
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

7.  Novel syntaxin 11 gene (STX11) mutation in three Argentinean patients with hemophagocytic lymphohistiocytosis.

Authors:  Silvia Danielian; Natalia Basile; Carlos Rocco; Emma Prieto; Jorge Rossi; Darío Barsotti; Paul A Roche; Andrea Bernasconi; Matías Oleastro; Marta Zelazko; Jorge Braier
Journal:  J Clin Immunol       Date:  2009-12-05       Impact factor: 8.317

8.  A Novel Syntaxin 11 Gene (STX11) Mutation c.650T>C, p.Leu217Pro, in a Korean Child With Familial Hemophagocytic Lymphohistiocytosis.

Authors:  Ardak K Sultanova; Seong-koo Kim; Jae Wook Lee; Pil-Sang Jang; Nack-Gyun Chung; Bin Cho; Joonhong Park; Yonggoo Kim; Myungshin Kim
Journal:  Ann Lab Med       Date:  2016-03       Impact factor: 3.464

9.  Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11.

Authors:  Udo zur Stadt; Jan Rohr; Wenke Seifert; Florian Koch; Samantha Grieve; Julia Pagel; Julia Strauss; Brigitte Kasper; Gudrun Nürnberg; Christian Becker; Andrea Maul-Pavicic; Karin Beutel; Gritta Janka; Gillian Griffiths; Stephan Ehl; Hans Christian Hennies
Journal:  Am J Hum Genet       Date:  2009-10       Impact factor: 11.025

10.  Spinal cord involvement in a child with familial hemophagocytic lymphohistiocytosis.

Authors:  Muge Gokce; Gunay Balta; Sule Unal; Kader Oguz; Mualla Cetin; Fatma Gumruk
Journal:  J Pediatr Neurosci       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.